Back to search

A combination of factor Xa and phosphatidylcholine-phosphatidylserine vesicles bypasses factor VIII in vivo

Data up to Jan 2025

Published1988
Citations49
References25

Total Citations Per Year

Abstract

References (25)

Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens

1957 • 3,280 citations

Molecular Weight Determination of Protein-Dodecyl Sulfate Complexes by Gel Electrophoresis in a Discontinuous Buffer System

1971 • 2,019 citations

The Journal of Laboratory and Clinical Medicine

2004 • 1,433 citations

Immunoblotting and dot immunobinding — Current status and outlook

1984 • 979 citations

The contribution of bovine Factor V and Factor Va to the activity of prothrombinase.

1979 • 592 citations

The inhibition of blood coagulation by activated protein C through the selective inactivation of activated factor V

1979 • 480 citations

Molecular mechanism of physiological fibrinolysis

1978 • 410 citations

The Effect of Activated Prothrombin-Complex Concentrate (FEIBA) on Joint and Muscle Bleeding in Patients with Hemophilia A and Antibodies to Factor VIII

1981 • 303 citations

Generation of fibrinolytic activity by infusion of activated protein C into dogs.

1981 • 303 citations

Efficacy of Prothrombin-Complex Concentrates in Hemophiliacs with Antibodies to Factor VIII

1980 • 257 citations

Use of human factor VIIa in the treatment of two hemophilia A patients with high-titer inhibitors.

1983 • 239 citations

Simultaneous Purification of Bovine Prothrombin and Factor X

1973 • 204 citations

Activated Prothrombin Concentrate for Patients with Factor VIII Inhibitors

1974 • 163 citations

Human prothrombin activation

1975 • 131 citations

A canine model of hemophilic (factor VIII:C deficiency) bleeding

1982 • 128 citations

Autoplex versus proplex: a controlled, double-blind study of effectiveness in acute hemarthroses in hemophiliacs with inhibitors to factor VIII

1983 • 125 citations

Factor VIII inhibitors

1985 • 109 citations

Intravascular Coagulation with Use of Human Prothrombin Complex Concentrates

1976 • 91 citations

The coagulant-active phospholipid content is a major determinant of in vivo thrombogenicity of prothrombin complex (Factor IX) concentrates in rabbits

1982 • 81 citations

Treatment of Anti-Factor VIII Antibodies

1977 • 80 citations

Evidence of normal functional levels of activated protein C inhibitor in combined Factor V/VIII deficiency disease.

1982 • 77 citations

[26] Protein C

1981 • 67 citations

Studies of Factors V and VIII:C in an animal model of disseminated intravascular coagulation.

1984 • 46 citations

FACTOR VIII INHIBITORS REVISITED

1981 • 35 citations

Isolation of human VAL354-plasminogen as an elastolytic fragment of human GLU1-plasminogen

1981 • 22 citations

Cited By (0)

Loading...
A combination of factor Xa and phosphatidylcholine-phosphatidylserine vesicles bypasses… (1988) – British Journal of Haematology | Metascience Observatory Explorer